The life expectancy of patients with ALD (adrenoleukodystrophy) can vary greatly depending on several factors, including the type of ALD, the age of onset, and the severity of the condition. Generally, the earlier the onset and the more severe the condition, the shorter the life expectancy.
In classic, or childhood-onset, ALD, most patients live to adulthood, although the severity of symptoms can vary greatly. In some cases, the condition may be mild and patients may have a normal life expectancy. In more severe cases, life expectancy may be reduced by 10-20 years.
In adult-onset ALD, life expectancy is more difficult to predict but is typically much shorter than in classic ALD. Most adult-onset patients experience rapid progression of their symptoms and death typically occurs within 5-10 years of diagnosis.
Overall, the life expectancy of ALD patients depends on the type, age of onset, and severity of the condition. While some patients may experience a normal life expectancy, others may experience a reduced life expectancy. It is important to discuss treatment options with a doctor to determine the best course of action for each individual patient.